The Chartis Group, a portfolio company of Riordan, Lewis & Haden, has been sold to Audax Private Equity
Lincoln worked closely with shareholders and management to find the right partner for the business to continue its growth trajectory. This was a global advisory engagement providing transaction expertise and managing the preparatory, marketing, negotiating, and diligence phases of the process.
The Chartis Group is a mission-based, values-driven firm and a leading provider of comprehensive advisory and analytics services to the healthcare industry. Since inception, the company’s unyielding mission has been to materially improve the delivery of healthcare in the world. Chartis provides a comprehensive, cross-functional approach to clients’ most pressing and complex needs that is unmatched in the industry and has firmly established the Company as a nationally recognized, premium brand.
Ken Graboys, CEO of Chartis commented, “Lincoln’s deep understanding of our unique business model and culture and senior-level dedication throughout the process were instrumental in achieving a successful outcome with the right partner that allows Chartis to continue its growth trajectory and help our clients achieve unrivaled results.”
Rob Zielinski, Partner at Riordan, Lewis & Haden, added, “Lincoln’s global platform and access to key decision makers were critical in securing an exceptional new long-term partner for Chartis.”
Lincoln’s execution expertise and partnership approach with management created a highly efficient process, resulting in a great outcome for Chartis’ shareholders and management team.
Meet our Senior Team
My goal is to inspire and motivate our people to make a true impact with their clients, their colleagues and their communities.
Managing Director | CEO North AmericaChicago
View More Transactions
Lincoln International has advised Airsweb on its sale to EcoOnline, a Norway-based company backed by Goldman Sachs, Summa Equity and Viking Venture
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that Sparton Corporation, a portfolio company of Cerberus Capital Management, L.P. (together with its affiliates, “Cerberus”), has sold its manufacturing and design services division (“MDS”) to One Equity Partners
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack